AU2002315398A1 - Methods and compositions useful for the prediction of blood-brain barrier permeation - Google Patents

Methods and compositions useful for the prediction of blood-brain barrier permeation

Info

Publication number
AU2002315398A1
AU2002315398A1 AU2002315398A AU2002315398A AU2002315398A1 AU 2002315398 A1 AU2002315398 A1 AU 2002315398A1 AU 2002315398 A AU2002315398 A AU 2002315398A AU 2002315398 A AU2002315398 A AU 2002315398A AU 2002315398 A1 AU2002315398 A1 AU 2002315398A1
Authority
AU
Australia
Prior art keywords
prediction
blood
methods
brain barrier
compositions useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002315398A
Inventor
Li Di
Edward Harvel Kerns
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Original Assignee
Wyeth LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth LLC filed Critical Wyeth LLC
Publication of AU2002315398A1 publication Critical patent/AU2002315398A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Endocrinology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
AU2002315398A 2001-06-29 2002-06-20 Methods and compositions useful for the prediction of blood-brain barrier permeation Abandoned AU2002315398A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US30208501P 2001-06-29 2001-06-29
US60/302,085 2001-06-29
PCT/US2002/019736 WO2003003007A2 (en) 2001-06-29 2002-06-20 Methods and compositions useful for the prediction of blood-brain barrier permeation

Publications (1)

Publication Number Publication Date
AU2002315398A1 true AU2002315398A1 (en) 2003-03-03

Family

ID=23166189

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002315398A Abandoned AU2002315398A1 (en) 2001-06-29 2002-06-20 Methods and compositions useful for the prediction of blood-brain barrier permeation

Country Status (8)

Country Link
EP (1) EP1399539A2 (en)
JP (1) JP2005501230A (en)
AR (1) AR036121A1 (en)
AU (1) AU2002315398A1 (en)
BR (1) BR0210697A (en)
CA (1) CA2448746A1 (en)
MX (1) MXPA03011439A (en)
WO (1) WO2003003007A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE453119T1 (en) 2002-01-31 2010-01-15 Pion Inc METHOD AND DEVICE FOR MEASURING MEMBRANE PERMEABILITY
US8986781B2 (en) * 2005-10-27 2015-03-24 Corning Incorporated Immobilized multi-layer artificial membrane for permeability measurements (PAMPA)
DE102008007673A1 (en) * 2008-01-25 2009-07-30 Nimbus Biotechnologie Gmbh Determination of the permeability of substances through the blood-brain barrier
US10143187B2 (en) 2017-02-17 2018-12-04 Denali Therapeutics Inc. Transferrin receptor transgenic models
DK3583120T3 (en) 2017-02-17 2022-12-19 Denali Therapeutics Inc MODIFIED TRANSFERRIN RECEPTOR BINDING POLYPEPTIDES
US10457717B2 (en) 2017-02-17 2019-10-29 Denali Therapeutics Inc. Engineered polypeptides

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260210A (en) * 1989-09-27 1993-11-09 Rubin Lee L Blood-brain barrier model

Also Published As

Publication number Publication date
CA2448746A1 (en) 2003-01-09
BR0210697A (en) 2004-09-21
JP2005501230A (en) 2005-01-13
MXPA03011439A (en) 2004-04-05
WO2003003007A3 (en) 2003-05-22
EP1399539A2 (en) 2004-03-24
WO2003003007A2 (en) 2003-01-09
AR036121A1 (en) 2004-08-11

Similar Documents

Publication Publication Date Title
AU2002357119A1 (en) Mitocidal compositions and methods
AU2002255190A1 (en) Composition for enhanced absorption of nsaids
AU2001276588A1 (en) Adaptive-block-length audio coder
AU2002323381A1 (en) Deodorant composition
EP1628530B8 (en) Methods and compositions for the prevention and treatment of sepsis
AU2002355904A1 (en) Perfume-containing composition
AU2002302147A1 (en) Pharmaceutical composition
AU2002238843A1 (en) Navigator
AU2002241114A1 (en) Composition
AU2002357748A1 (en) Osteopontin-related compositions and methods
AU2002326745A1 (en) Compositions and methods for generating antigen-binding units
AU2002359026A1 (en) Compositon of dentifrice
AU2002315398A1 (en) Methods and compositions useful for the prediction of blood-brain barrier permeation
AU2001255754A1 (en) Methods and compositions for the manufacture of molecular beacons
AU2002303552A1 (en) Methods and compositions for prevention of angioproliferation
AU2002359869A1 (en) Pak5-related compositions and methods
AU2002240301A1 (en) Mild foaming cleanser composition
AU2002302421A1 (en) Shampoo compositions
AUPR668401A0 (en) Pharmaceutical composition
AU2002345799A1 (en) Pharmaceutical composition
AU2002344087A1 (en) Pharmaceutical composition
AU2002316418A1 (en) Pharmaceutical composition
AU2002355455A1 (en) Composite compositions
AU2002337919A1 (en) Methods for preventing or reversing asthma and compositions useful therefor
AU2002326822A1 (en) Pro-micelle pharmaceutical compositions

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase